Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xelect is a Scottish aquaculture genetics company that provides breeding programme management, genomics services, and laboratory testing for fish, shrimp, and shellfish producers. Founded as a University of St Andrews spin-out, the company helps aquaculture clients improve growth, survival, resilience, and other commercially important traits through selective breeding, genotyping, bioinformatics, and decision-support software. Its offerings include breeding programme design, genomic selection support, pedigree reconstruction, sex determination, ploidy analysis, and related laboratory services. Xelect also develops proprietary software and modeling tools, including Optimate and Ximulate, to optimize breeding decisions and manage genetic diversity. The company is commercially operating and, since December 2023, has been part of Genus plc.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xelect.